Non-metastatic Castration-resistant Prostate Cancer

9 clinical trials · Condition

Record	Firm	Date
An Observational Study, Called DEAR, to Learn More About Treatment With Darolutamide, Enzalutamide and Apalutamide in Men With Non-metastatic Castration-resistant Prostate Cancer in Real World Settings (NCT05362149)	Bayer	2022-04-04
Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer (NCT04666129)	Sumitomo Pharma America, Inc.	2021-02-18
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1) (NCT03493945)	National Cancer Institute (NCI)	2018-05-01

Every clearance here is in the API, with alerts when new ones post.